What trial design can distinguish amyloid lowering that is causally upstream of cognitive benefit from amyloid lowering that is an insufficient biomarker response?

Evidence span

What trial design can distinguish amyloid lowering that is causally upstream of cognitive benefit from amyloid lowering that is an insufficient biomarker response?

Method & conditions

Evidence type

theoretical

Method

manual state transition

Conditions

Candidate gap for maintainer review; not a guaranteed experiment target.

Replicated

not yet

Confidence basis

operator-supplied frontier prior; review required